Skip to main content

Shellie-Anne Levy, PhD

Clinical Neuropsychologist

Photo of Shellie-Anne Levy

Research at a glance

Top areas of exploration

  • Neuropsychological Tests , 8 publications
  • Cognition , 7 publications
  • Biomarkers , 5 publications
  • Brain , 5 publications

Research activity

32 publications

373 citations

Why is this important?

Focus

Dr. Levy leads The Brain Health Equity and Dementia Prevention Lab: https://levy.chp.phhp.ufl.edu/. Her research program focuses on studying cognitive aging in older adults with MCI and neurodegenerative disorders (i.e., Alzheimer’s disease and related disorders). Broadly, her research goals are to better understand the health, psychosocial disparities, and resiliency factors that influence the onset, diagnosis, and treatment of these disorders in at-risk and understudied populations. Her work has spanned 1) examining behavioral/lifestyle interventions for mild cognitive impairment (MCI) that will improve functional outcomes in individuals at risk for progression to dementia, 2) elucidating barriers to participation in behavioral intervention research for MCI amongst minoritized communities, and 3) examining vascular-related factors, cardiometabolic health conditions, and disparate cognitive aging outcomes in diverse populations. She has received funding from federal and non-profit organizations to support her work. She is also supported by the Center for Cognitive Aging and Memory and The McKnight Brain Institute.

My publications

32 publications

2026

Factors associated with discordant visual and quantitative amyloid PET results

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

PubMed Publisher's site

2025

Symptom diagnosis codes informing under-diagnosis of Lewy body dementia in Medicare beneficiaries from different ethnoracial backgrounds

Journal of Alzheimer’s Disease

PubMed Publisher's site

2025

Cognitive factor structure of the NACC UDS-3 neuropsychological battery across ethno-racial, linguistic, and cognitive status groups

The Clinical Neuropsychologist

Publisher's site

2025

Moderating effects of plasma glial fibrillary acidic protein along the Alzheimer's disease continuum.

Alzheimer's & dementia : the journal of the Alzheimer's Association

PubMed Publisher's site

2025

Sex and ethnicity in early-onset Alzheimer's disease biomarkers and global function.

Alzheimer's & dementia (Amsterdam, Netherlands)

PubMed Publisher's site